切换至 "中华医学电子期刊资源库"

中华卫生应急电子杂志 ›› 2024, Vol. 10 ›› Issue (01) : 16 -20. doi: 10.3877/cma.j.issn.2095-9133.2024.01.004

论著

血清细胞因子预测急性脑梗死后肺炎的价值
南朝涛1, 陈建2, 王书鸿2, 李刚2, 郝俊杰2,()   
  1. 1. 200120 上海,同济大学附属东方医院神经内科暨脑卒中中心;456200 河南,河南省浚县脑血管病医院神经内科
    2. 200120 上海,同济大学附属东方医院神经内科暨脑卒中中心
  • 收稿日期:2024-01-08 出版日期:2024-02-18
  • 通信作者: 郝俊杰
  • 基金资助:
    上海市浦东新区高原学科建设计划(PWYgy2021-05); 上海市临床重点专科(shslczdzk06103)

Value of serum cytokines in predicting pneumonia secondary to acute cerebral infarction

Chaotao Nan1, Jian Chen2, Shuhong Wang2, Gang Li2, Junjie Hao2,()   

  1. 1. Department of Neurology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China; Department of Neurology, Junxian Cerebrovascular Hospital, Henan 456200, China
    2. Department of Neurology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China
  • Received:2024-01-08 Published:2024-02-18
  • Corresponding author: Junjie Hao
引用本文:

南朝涛, 陈建, 王书鸿, 李刚, 郝俊杰. 血清细胞因子预测急性脑梗死后肺炎的价值[J/OL]. 中华卫生应急电子杂志, 2024, 10(01): 16-20.

Chaotao Nan, Jian Chen, Shuhong Wang, Gang Li, Junjie Hao. Value of serum cytokines in predicting pneumonia secondary to acute cerebral infarction[J/OL]. Chinese Journal of Hygiene Rescue(Electronic Edition), 2024, 10(01): 16-20.

目的

研究血清细胞因子与急性脑梗死后肺炎发生的相关性并探讨其预测价值。

方法

选取在同济大学附属东方医院神经内科重症病房收治的99例急性脑梗死患者为研究对象,其中男性70例(70.71%),女性29例(29.29%);年龄27~95岁,平均(67±13)岁。发病48 h内检测血清十二项细胞因子浓度,包括白细胞介素(interleukin,IL)-1β,IL-2,IL-4,IL-5,IL-6,IL-8,IL-10,IL-12P70,IL-17A,干扰素(interferon,IFN)-α,IFN-γ,肿瘤坏死因子(tumor necrosis factor,TNF)-α以及血清白蛋白、球蛋白、外周血白细胞计数、外周血淋巴细胞计数;依据研究对象其后是否发生肺炎分为肺炎组(44例)和非肺炎组(55例),应用二元Logistic回归分析明确十二项细胞因子是否为急性脑梗死后肺炎发生的独立预测因素。

结果

二元Logistic回归分析显示,血清IL-10浓度升高(OR 1.24,95%CI 1.01~1.52,P=0.039)和外周血白细胞计数增加(OR 1.50,95%CI 1.18~1.92,P=0.001)为急性脑梗死后肺炎的独立预测因素,发病48 h内血清IL-10>2.50ng/L预测急性脑梗死后肺炎的敏感度为61.36%,特异度为64.29%,外周血白细胞>10.00×109/L的敏感度为50.00%,特异度为81.48%,两者联合预测急性脑梗死后肺炎的敏感度为34.09%,特异度为83.33%。

结论

急性脑梗死早期血清IL-10升高和外周血白细胞计数增加有助于预测急性脑梗死后肺炎的发生,特异度较高、但敏感度较低。

Objective

To investigate the correlation between serum cytokines and pneumonia secondary to acute cerebral infarction (ACI) .

Methods

99 patients with acute cerebral infarction admitted to the Neurology Intensive Care Unit of Dongfang Hospital Affiliated to Tongji University were selected as the study subjects, including 70 males (70.71%) and 29 females (29.29%); The age range is from 27 to 95 years old, with an average of (67±13) years old. Within 48 hours of onset, serum concentrations of twelve cytokines, including interleukin-1, were detected β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12P70, IL-17A, interferon (IFN)-α, IFN- γ, Tumor necrosis factor (TNF)-α And serum albumin, globulin, peripheral blood leukocyte count, peripheral blood lymphocyte count; According to whether the research subjects developed pneumonia afterwards, they were divided into pneumonia group (44 cases) and non pneumonia group (55 cases). Binary logistic regression analysis was used to determine whether the twelve cytokines were independent predictors of pneumonia after acute cerebral infarction.

Results

Binary logistic regression analysis showed that the increased serum IL-10 (OR 1.24, 95% CI 1.01-1.52, P=0.039) and increased peripheral blood WBC counts (OR 1.50, 95% CI 1.18-1.92, P=0.001) were independent predictors for ACI secondary pneumonia. To predict ACI secondary pneumonia, the sensitivity and specificity of serum IL-10>2.50 ng/L within 48 hours of ACI, were 61.36% and 64.29%; the sensitivity and specificity of peripheral blood WBC counts>10.00×109/L within 48 hours of ACI, were 50.00% and 81.48%; the sensitivity and specificity of the combination of the two were 34.09% and 83.33%, respectively.

Conclusion

At the early stage of ACI, increased serum IL-10 and peripheral blood WBC counts have a certain diagnostic value for ACI secondary pneumonia, with high specificity but low sensitivity.

表1 两组患者研究指标的单因素分析[ng/L,MQ1,Q3)]
表2 两组患者研究指标的单因素分析[ng/L,MQ1,Q3)]
表3 两组患者研究指标的单因素分析[ng/L,MQ1,Q3)]
表4 两组患者研究指标的单因素分析[×109/L,MQ1,Q3)]
表5 二元Logistic回归分析
表6 预测指标敏感度与特异度[例(%)]
[1]
de Jonge JC, van de Beek D, Lyden P, et al. Temporalprofile of pneumonia after stroke[J]. Stroke, 2022, 53(3): 53-60.
[2]
Li X, Yu J, Shu C. Bibliometric analysis of global research trends on post-stroke pneumonia: current development status and research frontiers[J]. Front Public Health, 2022(10): 950859.
[3]
Zapata-Arriaza E, Mancha F, Bustamante A, et al. Biomarkers predictive value for early diagnosis of stroke-associated pneumonia[J]. Ann Clin Transl Neurol, 2019, 6(9): 1882-1887.
[4]
Chen J, Li X, Huang C, et al. Change of serum inflammatory cytokines levels in patients with chronic obstructive pulmonary disease, pneumonia and lung cancer[J]. Technol Cancer Res Treat, 2020(19): 1533033820951807.
[5]
中国卒中学会急救医学分会,中华医学会急诊医学分会卒中学组,中国老年医学学会急诊医学分会, 等. 卒中相关性肺炎诊治中国专家共识(2019更新版)[J]. 中华急诊医学杂志, 2019, 28(12): 1476-1484.
[6]
Tanaka T, Narazaki M, Kishimoto T. Interleukin (IL-6)immunotherapy[J]. Cold Spring Harb Perspect Biol, 2018, 10(8): a028456.
[7]
Hirano T. IL-6 in inflammation, autoimmunity and cancer[J]. Int Immunol, 2021, 33(3): 127-148.
[8]
Rasquinha MT, Sur M, Lasrado N, et al. IL-10 as a th2 cytokine: differences between mice and humans[J]. J Immunol, 2021, 207(9): 2205-2215.
[9]
Bedke T, Muscate F, Soukou S, et al. Title: IL-10-producing t cells and their dual functions[J]. Semin Immunol, 2019(44): 101335.
[10]
Liu DD, Chu SF, Chen C, et al. Research progress in stroke-induced immunodepression syndrome(SIDS)and stroke-associated pneumonia(SAP)[J]. Neurochem Int, 2018(114): 42-54.
[11]
Grossmann I, Rodriguez K, Soni M, et al. Stroke and pneumonia: mechanisms, risk factors, management, and prevention[J]. Cureus, 2021, 13(11): e19912.
[12]
Guo T, Dou L, Zhou X. Risk factors of stroke complicated with hospital-acquired pneumonia: a systematic review and meta-analysis of cohort studies[J]. Ann Palliat Med, 2021, 10(12): 12381-12389.
[13]
Zhang SY, Huang J, Zhou XL. A Meta-analysis of the Risk Factors for Stroke-associated Pneumonia[J]. J Coll Physicians Surg Pak, 2023, 33(7): 799-803.
[14]
Zawiah M, Hayat Khan A, Abu Farha R, et al. Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio, and platelet-lymphocyte ratio in stroke-associated pneumonia: a systematic review and meta-analysis[J]. Curr Med Res Opin, 2023, 39(3): 475-482.
[15]
Ni J, Shou W, Wu X, et al. Prediction of stroke-associated pneumonia by the A2DS2, AIS-APS, and ISAN scores: a systematic review and meta-analysis[J]. Expert Rev Respir Med, 2021, 15(11): 1461-1472.
[1] 张胜伟, 孟召路, 热汗古丽·吾休尔, 万世森, 闫鹏, 阳乔. 肺炎支原体诱发反应性感染性皮疹黏膜疹一例[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 309-313.
[2] 张燕, 杨跃青, 邱峥. IgG 联合血清细胞因子对肺结核并发慢性肺曲霉菌病的诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 809-812.
[3] 胡菊英, 李银华, 洪兰, 王宏勇, 丁先军, 李承美, 谭心海. 儿童感染大叶性肺炎与支气管肺炎临床特征分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 813-816.
[4] 晏彦, 杨军, 周凤兰, 孙登昆, 陈玉. 哌拉西林他唑巴坦和哌拉西林舒巴坦治疗细菌性肺炎的倾向性匹配分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 817-819.
[5] 于燕兴, 梅喜庆, 刘凤娟, 于梓薇, 许亚慧, 徐飞. 高通量测序重症肺炎肺泡灌洗液病原体的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 785-788.
[6] 刘雯, 赵明栋, 夏伟, 潘以雄. 不同剂量比阿培南治疗重症肺炎的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 789-792.
[7] 董大红, 周明虎, 李芝朋, 许正峰. 碳青霉烯类抗生素联合呼吸机治疗肺部感染的临床疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 793-796.
[8] 刘春军, 严方方, 王宝锋, 常婷婷, 郭红红, 李志强. 替加环素联合人免疫球蛋白治疗XDRAB致VAP 的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 797-800.
[9] 傅红兴, 王植楷, 谢贵林, 蔡娟娟, 杨威, 严盛. 间充质干细胞促进胰岛移植效果的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 351-360.
[10] 谢井伟, 王森, 王非, 郭永坤. STA-MCA血管搭桥术治疗烟雾病[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 318-320.
[11] 王永楠, 汤畅通, 殷杰, 谭溢涛. 微创钻孔引流术与神经内镜血肿清除术治疗临界量基底节脑出血的效果对比分析[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 286-292.
[12] 丛黎, 马林, 陈旭, 李文文, 张亮亮, 周华亭. 改良CT严重指数联合炎症指标在重症急性胰腺炎患者胰腺感染预测及预后评估中的研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 432-436.
[13] 杨卫东, 周威, 向洪涛. 慢性萎缩性胃炎患者幽门螺杆菌感染与炎性细胞因子及病理特征的关系[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 459-464.
[14] 李润东, 豆小文, 张秀明. 失笑散联合胃复春治疗慢性萎缩性胃炎的疗效及对血清免疫受体和炎症因子水平的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 470-473.
[15] 克地尔牙·马合木提, 胡波, 杨琼, 闫素, 胡岚卿, 高沛沛, 姚恩生. 依达拉奉右莰醇对急性脑梗死后认知功能障碍的疗效观察[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 459-466.
阅读次数
全文


摘要